These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


254 related items for PubMed ID: 15503281

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers.
    Palomaki GE, Steinort K, Knight GJ, Haddow JE.
    Obstet Gynecol; 2006 Feb; 107(2 Pt 1):367-75. PubMed ID: 16449126
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cross-trimester marker ratios in prenatal screening for Down syndrome.
    Wald NJ, Bestwick JP, Morris JK.
    Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232
    [Abstract] [Full Text] [Related]

  • 8. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
    Maymon R, Cuckle H, Jones R, Reish O, Sharony R, Herman A.
    Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
    [Abstract] [Full Text] [Related]

  • 9. Advances in antenatal screening for Down syndrome.
    Wald NJ, Hackshaw AK.
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Aug; 14(4):563-80. PubMed ID: 10985931
    [Abstract] [Full Text] [Related]

  • 10. Repeated measures screening for Down's Syndrome.
    Wright DE, Bradbury I.
    BJOG; 2005 Jan; 112(1):80-3. PubMed ID: 15663402
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters.
    Cuckle H, Benn P, Wright D.
    Semin Perinatol; 2005 Aug; 29(4):252-7. PubMed ID: 16104677
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Integrated serum screening for Down syndrome in primary obstetric practice.
    Knight GJ, Palomaki GE, Neveux LM, Smith DE, Kloza EM, Pulkkinen AJ, Williams J, Haddow JE.
    Prenat Diagn; 2005 Dec; 25(12):1162-7. PubMed ID: 16231402
    [Abstract] [Full Text] [Related]

  • 17. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA, Ying J, Beazoglou T, Egan JF.
    Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
    [Abstract] [Full Text] [Related]

  • 18. Contingent screening for Down syndrome--results from the FaSTER trial.
    Cuckle HS, Malone FD, Wright D, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Ferreira JC, Dugoff L, Craigo SD, Timor IE, Carr SR, Wolfe HM, D'Alton ME.
    Prenat Diagn; 2008 Feb; 28(2):89-94. PubMed ID: 18236423
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O.
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.